Antti L.
- Country
- Finland
- Department
- Savon Psykiatripalvelu Oy
Research Overview
- Efficacy and Safety Evaluation of ITI-1284 as Adjunctive Therapy in Generalized Anxiety Disorder Patients with Inadequate Response to Standard Treatment
- Efficacy and Safety of Aticaprant as Adjunctive Therapy in Adults with Major Depressive Disorder and Anhedonia Unresponsive to Antidepressants
- A Phase 2/3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose, Multicenter Study to Evaluate the Efficacy and Safety of SEP 363856 in the Treatment of Adults with Generalized Anxiety Disorder
Data & Insights
Has run more than one trial at 52 of 159 partner sites.
Specializations
Sleep Medicine
The investigator focuses on treating patients with insomnia disorder, exploring innovative therapeutic approaches for sleep regulation and management.
- Sleep disorders assessment
- Novel sleep medications
- Sleep regulation therapies
Particular emphasis is placed on evaluating new therapeutic agents for improving sleep quality and duration.
Anxiety Disorders
The investigator specializes in treating generalized anxiety disorder (GAD), exploring advanced therapeutic options for anxiety management.
- Anxiety assessment tools
- Novel anxiolytic treatments
- GAD therapeutic interventions
Clinical focus includes evaluation of innovative treatments for anxiety symptom reduction.
Mood Disorders
The investigator concentrates on treating major depressive disorder (MDD) with particular attention to cases involving moderate-to-severe anhedonia.
- Treatment-resistant depression
- Adjunctive therapy approaches
- Anhedonia management
Special interest in developing combination treatments for patients with inadequate response to standard antidepressants.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.